MedPath

The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin

Conditions
Blood Coagulation Disorders
Registration Number
NCT02782338
Lead Sponsor
Wolfson Medical Center
Brief Summary

A prospective study intended to examine the effect of topical Voltaren-Ophtha 0.1% eye drops after cataract surgery on INR levels (international normalized ratio) in patients taking warfarin.

Detailed Description

Objective: To examine the effect of topical Voltaren-Ophtha 0.1% eye drops after cataract surgery on INR levels ( international normalized ratio) in patients taking warfarin.

Methods: A prospective study. The study population will include approximately 100 patients, taking warfarin and that are candidates for cataract surgery. These patients will continue their warfarin therapy as usual and at the same dose, before and after the operation.

INR levels (international normalized ratio) will be checked once a week while taking Voltaren eye drops as is customary after cataract surgery.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  • people taking warfarin
  • candidates for cataract surgery
Exclusion Criteria
  • age <18 years
  • pregnant women

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
INR levels (international normalized ratio) - change is being assessed1 week, 2 weeks, 3 weeks and 4 weeks after taking Voltaren Optha 0.1%

change is being assessed

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath